Susquehanna International Group, LLP Oncolytics Biotech Inc Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.22 - $2.09 $36,973 - $63,339	30,306 New	30,306 $40,000
Q2 2022 Aug 15, 2022	BUY	$0.85 - $1.59 $60,491 - $113,155	71,167 New	71,167 $70,000
Q1 2022 May 16, 2022	SELL	$1.31 - $2.02 $13,177 - $20,319	-10,059 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$1.39 - $2.3 $13,982 - $23,135	10,059 New	10,059 $14,000
Q2 2019 Aug 14, 2019	SELL	$1.63 - $1.95 $16,533 - $19,778	-10,143 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$1.77 - $2.31 $7,830 - $10,219	-4,424 Reduced 30.37%	10,143 $19,000
Q4 2018 Feb 14, 2019	BUY	$1.72 - $4.12 $25,055 - $60,016	14,567 New	14,567 $26,000

1.25M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $42.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.